首页 正文

Targeting the TRIB3-MYC axis in cancer: mechanistic insights and therapeutic disruption strategies

{{output}}
The oncogenic transcription factor MYC drives proliferation, metabolism, and therapy resistance in the majority of human cancers, yet its large, nuclear protein-protein interface has long frustrated direct drug discovery. A pivotal breakthrough was the identif... ...